Journal article · 2023 · Open access
OP0219 INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH JAK-INHIBITORS COMPARED TO BDMARDS: DATA FROM AN INTERNATIONAL COLLABORATION OF REGISTRIES (THE “JAK-POT” STUDY)
Annals of the Rheumatic Diseases, 82, 143–145 · Published 1 June 2023 · DOI 10.1136/annrheumdis-2023-eular.660
In brief
“OP0219 INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH JAK-INHIBITORS COMPARED TO BDMARDS: DATA FROM AN INTERNATIONAL COLLABORATION OF REGISTRIES (THE “JAK-POT” STUDY)” is a 2023 journal article by R. Aymon and 29 co-authors, published in Annals of the Rheumatic Diseases. OpenAlex counts 6 citations as of 19 November 2026, which puts it in the top 7% of works published in 2023 by citations. It is open access: the full text is free to read at Annals of the Rheumatic Diseases.
- Citations
- 6
- Most cited in
- 2024 (4)
- Field-weighted impact
- 1.00
- References
- 1
- Authors
- 30
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Aymon, R., Mongin, D., Bergstra, S. A., Choquette, D., Codreanu, C., Cordtz, R., De Cock, D., Dreyer, L., Elkayam, O., Huschek, D., Hyrich, K. L., Iannone, F., İnanç, N., Kearsley‐Fleet, L., Kvien, T. K., Leeb, B. F., Lukina, G. V., Nordström, D., Önen, F., . . . Lauper, K. (2023). OP0219 INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH JAK-INHIBITORS COMPARED TO BDMARDS: DATA FROM AN INTERNATIONAL COLLABORATION OF REGISTRIES (THE “JAK-POT” STUDY). Annals of the Rheumatic Diseases, 82, 143–145. https://doi.org/10.1136/annrheumdis-2023-eular.660
MLA 9
Aymon, R., et al. “OP0219 INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH JAK-INHIBITORS COMPARED TO BDMARDS: DATA FROM AN INTERNATIONAL COLLABORATION OF REGISTRIES (THE “JAK-POT” STUDY).” Annals of the Rheumatic Diseases, vol. 82, 2023, pp. 143–145. https://doi.org/10.1136/annrheumdis-2023-eular.660.
Chicago
Aymon, R., Denis Mongin, Sytske Anne Bergstra, D. Choquette, Cătălin Codreanu, René Cordtz, Diederik De Cock, et al. 2023. “OP0219 INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH JAK-INHIBITORS COMPARED TO BDMARDS: DATA FROM AN INTERNATIONAL COLLABORATION OF REGISTRIES (THE “JAK-POT” STUDY).” Annals of the Rheumatic Diseases 82: 143–145. https://doi.org/10.1136/annrheumdis-2023-eular.660.
Harvard
Aymon, R. et al. (2023) ‘OP0219 INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH JAK-INHIBITORS COMPARED TO BDMARDS: DATA FROM AN INTERNATIONAL COLLABORATION OF REGISTRIES (THE “JAK-POT” STUDY)’, Annals of the Rheumatic Diseases, 82, pp. 143–145. doi:10.1136/annrheumdis-2023-eular.660.
IEEE
R. Aymon et al., “OP0219 INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH JAK-INHIBITORS COMPARED TO BDMARDS: DATA FROM AN INTERNATIONAL COLLABORATION OF REGISTRIES (THE “JAK-POT” STUDY),” Annals of the Rheumatic Diseases, vol. 82, pp. 143–145, 2023, doi: 10.1136/annrheumdis-2023-eular.660.
BibTeX
@article{aymon2023incidence,
title = {{OP0219 INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH JAK-INHIBITORS COMPARED TO BDMARDS: DATA FROM AN INTERNATIONAL COLLABORATION OF REGISTRIES (THE “JAK-POT” STUDY)}},
author = {Aymon, R. and Mongin, Denis and Bergstra, Sytske Anne and Choquette, D. and Codreanu, Cătălin and Cordtz, René and De Cock, Diederik and Dreyer, Lene and Elkayam, Ori and Huschek, Doreen and Hyrich, Kimme Leanne and Iannone, Florenzo and İnanç, Nevsun and Kearsley‐Fleet, Lianne and Kvien, Tore Kristian and Leeb, Burkhard F. and Lukina, Galina V and Nordström, Dan and Önen, Fatoş and Pavelká, Karel and Pombo‐Suárez, Manuel and Provan, Sella Aarrestad and Rodrigues, Ana Maria and Rotar, Žiga and Strangfeld, Anja and Verschueren, Patrick and Závada, Jakub and Courvoisier, Delphine Sophie and Finckh, Axel and Lauper, Kim},
journal = {Annals of the Rheumatic Diseases},
year = {2023},
volume = {82},
pages = {143--145},
doi = {10.1136/annrheumdis-2023-eular.660},
url = {https://doi.org/10.1136/annrheumdis-2023-eular.660}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- rheumatoid arthritis
- JAK inhibitors
- major adverse cardiovascular events
- TNF-alpha inhibitors
- biologic DMARDs
- cardiovascular safety
- stroke
- myocardial infarction
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Aymon, R., Mongin, D., Bergstra, S. A., Choquette, D., Codreanu, C., Cordtz, R., De Cock, D., Dreyer, L., Elkayam, O., Huschek, D., Hyrich, K. L., Iannone, F., İnanç, N., Kearsley‐Fleet, L., Kvien, T. K., Leeb, B. F., Lukina, G. V., Nordström, D., Önen, F., . . . Lauper, K. (2023). OP0219 INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH JAK-INHIBITORS COMPARED TO BDMARDS: DATA FROM AN INTERNATIONAL COLLABORATION OF REGISTRIES (THE “JAK-POT” STUDY). Annals of the Rheumatic Diseases, 82, 143–145. https://doi.org/10.1136/annrheumdis-2023-eular.660
How many times has this paper been cited?
6 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Annals of the Rheumatic Diseases: sign in and open the PDF from this page.
Who wrote this paper?
R. Aymon, Denis Mongin, Sytske Anne Bergstra, D. Choquette, Cătălin Codreanu, René Cordtz, Diederik De Cock, Lene Dreyer, Ori Elkayam, Doreen Huschek, Kimme Leanne Hyrich, Florenzo Iannone and 18 more.
What is the DOI of this paper?
10.1136/annrheumdis-2023-eular.660, permanently at https://doi.org/10.1136/annrheumdis-2023-eular.660. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.